Simple Summary Outcomes for patients with acute promyelocytic leukemia (APL) have
improved over the past 40 years due to the development of targeted treatment regimens and …

Disseminated intravascular coagulation (DIC) is characterized by the intravascular activation
of coagulation with loss of localization arising from different causes, and is diagnosed using …

Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML),
classified by a translocation between chromosomes 15 and 17 [t (15; 17)], that is considered …

Acute promyelocytic leukemia (APL) is characterized by frequent complications due to a
distinct coagulopathy. While advances in treatments have improved long-term survival …

Hemorrhagic death is the leading cause of treatment failure in acute promyelocytic leukemia
(APL). Our ability to identify patients at greatest risk of hemorrhage, and to actively prevent …

Cancer patients face an elevated risk of bleeding, and here platelets play a pivotal role. The
association between platelet count and bleeding, as well as safe thresholds for prophylactic …

Recently, the main clinical treatment methods for tumor-associated hemorrhage include
systemic therapy, the application of hemostatic drugs, blood transfusion, symptomatic …

目的回顾性分析急性非早幼粒细胞白血病(ANPL) 早期颅内出血(ICH) 的高危因素,
建立预警评分系统. 方法纳入1 281 例ANPL 成人患者(模型组) 和378 例成人患者(验证组) …

Disseminated intravascular coagulation (DIC) is the result of an uncontrollable activation of
the coagulation cascade that can affect patients of all ages with different underlying …

Acute promyelocytic leukemia (APL) usually presents with a series of coagulation-
anticoagulation disturbance. Early administration of All-trans retinoic acid (ATRA) can …